Toll Group has announced it will build a 10,000 square metre healthcare warehouse and distribution centre at Tullamarine in Melbourne.
Toll is a leading supply chain partner to CSL Seqirus, and the facility is being custom built to support CSL Seqirus’ operations.
The state-of-the-art facility will be situated next to the future CSL Seqirus manufacturing site. It will assist Toll in providing tailored support for CSL Seqirus by handling both finished goods distribution and supplying raw materials and packaging to the CSL Seqirus manufacturing facility.
Toll’s warehouse and distribution centre is due to commence operations in August 2024.
According to Toll, the new warehouse marks its commitment to providing comprehensive logistics solutions for the healthcare sector. With operations commencing in Tullamarine, Toll aims to enhance efficiency and timeliness through just-in-time services.
“We are proud to strengthen our partnership with CSL Seqirus and expand our footprint in the healthcare logistics sector,” said Perry Singh, president, government and defence at Toll.
“This new facility exemplifies our commitment to delivering high-quality, tailored supply chain solutions to meet the evolving needs of our customers.”
In addition to the Tullamarine facility, in April 2023 Toll opened a new healthcare warehouse in Richlands, Queensland.
“The facilities are part of Toll’s broader multi-million-dollar investment creating advanced warehouse management solutions to meet the changing dynamics in the healthcare sector, and providing customers with the logistical support they need,” Singh added.
Toll’s facility will be situated adjacent to the soon-to-be-completed CSL Seqirus plant, a new world-class biotech manufacturing facility that will supply influenza vaccines to Australia and the rest of the world.